Gaviria BME, Gómez VLM

Language: Spanish
References: 50
Page: 79-88
PDF size: 369.19 Kb.

ABSTRACT

Brittle nail syndrome is the second most frequent reason for consultation about nail diseases in dermatology. It is characterized by onychorrhexis, onychoschizia and nail plate rupture as a result of systemic or dermatological diseases; nutritional deficiencies, environmental and occupational factors, that may affect the production or damage the already keratinised nails. This syndrome can be idiopathic and besides of its unpleasant cosmetic outcome, it has psychosocial impact, because the symptoms affect the daily life activities. Treatment is not easy, to identify the underlying cause and implement environmental control measures are a strong recommendations. Also on the market, there are a several hardeners available and oral supplementation of trace elements, amino acids and vitamins as biotin may be administered.

REFERENCES

1. Shemer A, Daniel CR III. Common nail disorders. Clin Dermatol. 2013; 31 (5): 578-586.

2. Iorizzo M, Pazzaglia M, Piraccini B, Tullo S, Tosti A. Brittle nails. J Cosmet Dermatol. 2004; 3: 138-144.

3. van de Kerkhof PCM, Pasch MC, Scher RK, Kerscher M, Gieler U, Haneke E, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005; 53: 644-651.

4. Baran R, Schoon D. Nail fragility syndrome and its treatment. J Cosmet Dermatol. 2004; 3 (3): 131-137.

5. Stern DK, Diamantis S, Smith E, Wei H, Gordon M, Muigai W et al. Water content and other aspects of brittle versus normal fingernails. J Am Acad Dermatol. 2007; 57 (1): 31-36.

6. Kechijian P. Brittle fingernails. Dermatol Clin. 1985; 3: 421-429.

7. Lubach D, Cohrs W, Wurzinger R. Incidence of brittle nails. Dermatológica. 1986; 172 (3): 144-147.

8. Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol. 1990; 23 (6 Pt 1): 1127-1132.

9. Gequelim GC, Kubota CY, Sanches S, Dranka D, Mejia MM, Sumiya FM et al. Perception of brittle nails in dermatologic patients: a cross-sectional study. An Bras Dermatol. 2013; 88 (6): 1022-1025.

10. Shelley WB, Shelley ED. Onychoschizia: scanning electron microscopy. J Am Acad Dermatol. 1984; 10: 623-627.

11. Uyttendaele H, Geyer A, Scher RK. Brittle nails: pathogenesis and treatment. J Drugs Dermatol. 2003; 2: 48-49.

12. de Berker D. The physical basis of cosmetic defects of the nail plate. J Cosm Dermatol. 2002; 1: 35-42.

13. Rowland-Payne CM. Brittle nails, fragile nails. J Cosmet Dermatol. 2004; 3 (3): 119-121.

14. Helmdach M, Thielitz A, Röpke EM, Gollnick H. Age and sex variation in lipid composition of human fingernail plates. Skin Pharmacol Appl Skin Physiol. 2000; 13: 111-119.

15. Lubach D, Beckers P. Wet working conditions increase brittleness of nails, but do not cause it. Dermatology. 1992; 185 (2): 120-213.

16. Dimitris R, Ralph D. Management of simple brittle nails. Dermatol Ther. 2012; 25 (6): 569-573.

17. Singh G, Haneef NS, Uday A. Nail changes and disorders among the elderly. Indian J Dermatol Venereol Leprol. 2005; 71 (6): 386-392.

18. Dogra A, Arora AK. Nail psoriasis: the journey so far. Indian J Dermatol. 2014; 59 (4): 319-333.

19. Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA. Nail psoriasis: a review of the literature. An Bras Dermatol. 2014; 89 (2): 312-317.

20. Rich P, Scher RK. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003; 49: 206-212.

21. Tosti A, Piraccini BM. Dermatological diseases. In: Nails: diagnosis, therapy, and surgery. Scher RK, Daniel CR III (Ed). Elsevier Saunders; 2005.

22. Goettmann S, Zaraa I, Moulonguet I. Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases. J Eur Acad Dermatol Venereol. 2012; 26 (10): 1304-1309.

23. Piraccini BM, Saccani E, Starace M, Balestri R, Tosti A. Nail lichen planus: response to treatment and long term follow-up. Eur J Dermatol. 2010; 20: 489-496.

24. de Berker D, Higgins C, Jahoda C, Christiano A. Biology of hair and nails. In: Dermatology. Bolognia J, Jorizo J, Schaffer J (Ed). Elsevier Saunders; 2012.

25. Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010; 24 (6): 649-654.

26. Duarte AF, Correia O, Baran R. Nail plate cohesion seems to be water independent. Int J Dermatol. 2009; 48: 193-195.

27. Rycroft RJG, Baran R. Occupational abnormalities and contact dermatitis. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 3rd ed. Oxford: Blackwell; 2001. pp. 1-79, 205-265, 279.

28. Garson JC, Baltenneck F, Leroy F, Riele C, Muller M. Histological structure of human nails as studied by synchroton X-ray microdiffraction. Cell Mol Biol. 2000; 46: 1025-1034.

29. Wallis MS, Bowen WR, Guin JD. Pathogenesis of onychoschizia (lamellar dystrophy). J Am Acad Dermatol. 1991; 24: 44-48.

30. Geyer AS, Onumah N, Uyttendaele H, Scher RK. Modulation of linear nail growth to treat diseases of the nail. J Am Acad Dermatol. 2004; 50: 229-234.

31. Draelos ZD. Understanding and treating brittle nails. Cosmet Dermatol. 2009; 22: 598-599.

32. Uyttendaele H, Geyer A, Scher RK. Brittle nails: pathogenesis and treatment. J Drugs Dermatol. 2003; 2 (1): 48-49.

33. Haneke E. Onychocomeceuticals. J Cosmet Dermatol. 2006; 5: 95-100.

34. Iorizzo M, Piraccini BM, Tosti A. Nail cosmetics in nail disorders. J Cosmet Dermatol. 2007; 1: 53-58.

35. Baran R, Andre J. Side effects of nail cosmetics. J Cosmet Dermatol. 2005; 4: 204-209.

36. Dahdah MJ, Scher R. Nail diseases related to nail cosmetics. Dermatol Clin. 2006; 24: 233-239.

37. Baran R. Hydroxypropyl chitosan accelerates nail growth in healthy fingernails and in mycotic toenails. Buenos Aires: Poster 21st World Congress of Dermatology; 2007.

38. Cantoresi F, Caserini M, Bidoli A, Maggio F, Marino R, Carnevale C et al. Randomized controlled trial of a water-soluble nail lacquer based on hydroxypropyl-chitosan (hPCh), in the management of nail psoriasis. Clin Cosmet Investig Dermatol. 2014; 7: 185-190.

39. Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone MF, Mailland F. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water soluble nail lacquer. Drug Dev Ind Pharm. 2005; 31: 11-17.

40. Sparavigna A, Caserini M, Tenconi B, De Ponti I, Palmieri R. effects of a novel nail lacquer based on hydroxypropyl-chitosan (HPCH) in subjects with fingernail onychoschizia. J Dermatolog Clin Res. 2004; 2 (2): 1013-1017.

41. Sparavigna A, Setaro M, Genet M, Frisenda L. Equisetum arvense in a new transungueal technology improves nail structure and appearance. Journal of Plastic Dermatology. 2006; 2 (1): 31-38.

42. Holzhuter G, Narayanan K, Gerber T. Structure of silica in Equisetum arvense. Anal Bioanal Chem. 2003; 376: 512-517.

43. Parcell S. Sulfur in human nutrition an application in medicine. Altern Med Rev. 2002; 7: 22-44.

44. Sparavigna A, Setaro M, Frisenda L. Physical and microbiological properties of a new nail protective medical device. J Cosmet Dermatol. 2008; 4: 5-12.

45. Sparavigna A, Setaro M, Frisenda L. Physical and microbiological properties of a new nail protective medical device. Journal of Plastic Dermatology. 2008; 4: 5-12.

46. Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993; 51: 303-305.

47. Scheinfeld N, Dahdah MJ, Scher R. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol. 2007; 6 (8): 782-787.

48. Iorizzo M. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin. 2015; 33 (2): 175-183.

49. Scheinfeld N, Dahdah MJ, Scher RK. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol. 2007; 6: 782-786.

50. Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol. 2010; 28 (4): 420-425.